Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kura Oncology (KURA) Return on Sales (2025 - 2026)

Kura Oncology has reported Return on Sales over the past 2 years, most recently at 0.04% for Q1 2026.

  • Quarterly Return on Sales changed 0.0% to 0.04% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.0% through Mar 2026, changed N/A year-over-year, with the annual reading at 0.0% for FY2025, 3.0% up from the prior year.
  • Return on Sales was 0.04% for Q1 2026 at Kura Oncology, down from 0.11% in the prior quarter.
  • Over five years, Return on Sales peaked at 0.11% in Q4 2025 and troughed at 0.04% in Q2 2025.